If this extension of the stay feels familiar, it might be because the same thing happened during the 2023 case challenging nationwide access to mifepristone. Alito extended it for two days before the court upheld the status quo and maintained access.
Here’s a refresher on the current case:
Advocates and opponents of abortion access say they’re wondering what happens next in a critical telehealth medication case that created chaos and confusion over the past week after an appeals court b...
